Emerging Options for Aortic Regurgitation

By Matti Adam, MD, and Jonathan Curio, MD

Comprehensive Multimodality Imaging Assessment of Aortic Regurgitation

A discussion of echocardiographic assessment combined with cardiac MR and CT for comprehensive aortic regurgitation evaluation.

By Takahiro Nishihara, MD; Go Hashimoto, MD; Stephanie Schmidt, RDCS; Paul Sorajja, MD; Vinayak Bapat, MD; Nadira Hamid, MD; Maurice Enriquez-Sarano, MD; and João L. Cavalcante, MD

Advances and Challenges in Aortic Regurgitation

Epidemiologic trends, current guidelines, and future directions.

By Joanna Bartkowiak, MD; Jonas Lanz, MD; Thomas Pilgrim, MD; and Fabien Praz, MD

Transcatheter Interventions for Pure AR: From Off-Label Use to Dedicated Devices

Challenges of TAVR in the treatment of pure aortic regurgitation and how dedicated devices can overcome them.

By Sara Waezsada, MD, and Tanja K. Rudolph, MD

TAVR for AR Spotlight: Do We Have a Pacemaker Issue?

Challenges with nondedicated and dedicated devices, uncertain predictors, and long-term implications.

By Hendrik Wienemann, MD

Literature Highlights: Study Endpoint Finds Early TAVR Superior to Clinical Surveillance for Asymptomatic, Severe Aortic Stenosis

With Hemal Gada, MD

Prepping the Room for PE Interventions

What (and who) to always have ready.

By Rohan Mundkur, MD; Akash Patel, MD; and Jonathan Paul, MD

Ask The Experts: How Does PE Clot Location/Distribution Affect Your Therapy Decision-Making?

Reflections on how device selection and therapeutic approach for pulmonary embolism are impacted by factors such as thrombus location, clot burden, and patient risk profile.

With Taisei Kobayashi, MD; Riyaz Bashir, MD, FACC, RVT; and Kenneth Rosenfield, MD, MHCDS

From Silos to Synergy: Strengthening Communication Between Cath Labs and Imaging Departments

Strategies for collaboration, efficiency, and enhanced patient outcomes.

By Jaime Warren, EdD, MBA, BHS, CNMT, NCT

An Interview With Felix Mahfoud, MD, MA

Prof. Mahfoud breaks down his translational cardiology research focused on the autonomic nervous system and interorgan communication in cardiovascular disease, remaining hurdles and research priorities for renal denervation, his work with the ESC and EAPCI, and more.